Changes in Energy Expenditure (EE) in Transsexuals Undergoing Hormonal Therapy
NCT06733415 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-12-13
Summary
Examining Metabolic Rate in Transgender individuals before starting hormonal treatment and 6-12 months after initiation
Conditions
- Transgender
- Transgender Persons, M01.777.500
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Principal Investigators
-
Yael Sofer, MD · Department of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center and Tel Aviv University
Eligibility
- Min Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-03
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Cardiometabolic Health in Transgender Males
NCT04977765 ·Status: ACTIVE_NOT_RECRUITING
-
Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth
NCT02550431 ·Status: COMPLETED
-
Transmasculine Quality of Life and Sexual Function at Pre and Post Gender-affirming Hormonal Therapy
NCT06482385 ·Status: COMPLETED
-
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
NCT06247267 ·Status: RECRUITING
-
Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
NCT04254354 ·Status: RECRUITING
-
Testosterone and Its Metabolites in GID
NCT00146146 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Hormone Therapy on Renal Function
NCT04482920 ·Status: COMPLETED
-
Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen
NCT04534881 ·Status: TERMINATED ·Phase: PHASE2
-
Subcutaneous Testosterone Project
NCT02229617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
NCT07092527 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
NCT04515472 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans
NCT05442463 ·Status: RECRUITING
-
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
NCT04478760 ·Status: COMPLETED
-
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
NCT04922424 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis
NCT05487794 ·Status: COMPLETED ·Phase: NA
-
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
NCT03864913 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Adaptions and Resiliency to Multi-Stressor OpeRations
NCT06455969 ·Status: RECRUITING ·Phase: PHASE4
-
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
NCT00075855 ·Status: COMPLETED ·Phase: PHASE3
-
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy
NCT06271551 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
GEnder Dysphoria Treatment in Sweden
NCT02518009 ·Status: COMPLETED
-
Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
NCT05302726 ·Status: UNKNOWN ·Phase: NA
-
Effect of Testosterone Treatment on Drug Metabolism and Transport
NCT05116293 ·Status: COMPLETED
-
Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure
NCT00957034 ·Status: TERMINATED ·Phase: PHASE2
-
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
NCT04049331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hormone Replacement Therapy to Treat Turner Syndrome
NCT00013546 ·Status: COMPLETED ·Phase: PHASE2